New Japan malaria vaccine cuts infections “by 72%” – Channel NewsAsiaPosted: May 31, 2013
Researchers from Osaka University have developed a dry powder vaccine, called BK-SE36, from a genetically-modified protein found inside the parasite, which they mixed with aluminium hydroxyl gel.
“The vaccine’s effect is greater than those hitherto reported of any other anti-malaria vaccines,” a statement issued this week said, adding BK-SE36 is expected to reduce markedly the number of deaths caused by the mosquito-borne disease.
The vaccine has already undergone trials on adults in Japan and was also tested in a malaria-endemic area in northern Uganda between 2010 and 2011. Neither study found any safety problems.
A follow-up study of people in Uganda, aged between six and 20, found the vaccine lowered the number of people infected by malaria by 72 per cent.
The findings were published on Tuesday on the online US science journal PLOS One, according the statement.